High prevalence of clinically unsuspected dengue disease among children in Ribeirao Preto city, Brazil

Journal of Medical Virology

Volumn 88, Issue 10, 2016, Pages 1711-1719

  Poloni, Telma Regina ^a   Dornas, Fabio Pio ^a   dos Santos, Nilton Nascimento ^a   Soares, Adriana Moreira ^a   Amarilla, Alberto Anastacio ^a   Alfonso, Helda Liz ^a   Trigueiro, Sabrina ^a   Lavrador, Marco Aurélio Sicchiroli ^a   Yamamoto, Aparecida Yulie ^a   Aquino, Victor Hugo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

blood; dengue virus; epidemiology; research and analysis methods; shedding

Indexed keywords

NONSTRUCTURAL PROTEIN 1;

ADOLESCENT; ANTIBODY RESPONSE; ARTICLE; BLOOD ANALYSIS; BRAZIL; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DENGUE; DENGUE VIRUS 1; DENGUE VIRUS 2; DENGUE VIRUS 3; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVA ANALYSIS; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; URINALYSIS; VIRUS GENOME; VIRUS IDENTIFICATION;

EID: 84979937147     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24533     Document Type: Article

References (62)

1. Abd Kadir SL, Yaakob H, Mohamed Zulkifli R. 2013. Potential anti-dengue medicinal plants: A review. J Nat Med 67:677–689.
2. Alfonso HL, Amarilla AA, Goncalves PF, Barros MT, de Almeida FT, Silva TR, da Silva EV, Nunes MT, Vasconcelos PFC, Vieira DS, Batista WC, Bobadilla ML, Vazquez C, Moran M, Moraes Figueiredo LT, Aquino VH. 2012. Phylogenetic relationship of dengue virus type 3 isolated in Brazil and Paraguay and global evolutionary divergence dynamics. Virol J 9:1–16.
3. Amarilla AA, de Almeida FT, Jorge DM, Alfonso HL, de Castro-Jorge LA, Nogueira NA, Figueiredo LT, Aquino VH. 2009. Genetic diversity of the e protein of dengue type 3 virus. Virol J 6:1–13.
4. Anders KL, Nguyet NM, Quyen NT, Ngoc TV, Tram TV, Gan TT, Tung NT, Dung NT, Chau NV, Wills B, Simmons CP. 2012. An evaluation of dried blood spots and oral swabs as alternative specimens for the diagnosis of dengue and screening for past dengue virus exposure. Am J Trop Med Hyg 87:165–170.
5. Aquino VH, Amarilla AA, Alfonso HL, Batista WC, Moraes Figueiredo LT. 2009. New genotype of dengue type 3 virus circulating in Brazil and Colombia showed a close relationship to old asian viruses. PLoS ONE 4:1–8.
6. Balmaseda A, Guzmán MG, Hammond S, Robleto G, Flores C, Téllez Y, Videa E, Saborio S, Pérez L, Sandoval E, Rodriguez Y, Harris E. 2003. Diagnosis of dengue virus infection by detection of specific immunoglobulin M (IgM) and IgA antibodies in serum and saliva. Clin Diagn Lab Immunol 10:317–322.
7. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG, Sankoh O, Myers MF, George DB, Jaenisch T, Wint GR, Simmons CP, Scott TW, Farrar JJ, Hay SI. 2013. The global distribution and burden of dengue. Nature 496:504–507.
8. Carneiro AR, Cruz AC, Vallinoto M, Melo DeV Ramos RT, Medeiros DB, Silva EV, Vasconcelos PF. 2012. Molecular characterisation of dengue virus type 1 reveals lineage replacement during circulation in Brazilian territory. Mem Inst Oswaldo Cruz 107:805–812.
9. Cavalcanti LP, Vilar D, Souza-Santos R, Teixeira MG. 2011. Change in age pattern of persons with dengue, Northeastern Brazil. Emerg Infect Dis 17:132–134.
10. Chakravarti A, Matlani M, Jain M. 2007. Immunodiagnosis of dengue virus infection using saliva. Curr Microbiol 55:461–464.
11. Chesters PM, Heritage J, McCance DJ. 1983. Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J Infect Dis 147:676–684.
12. Chuansumrit A, Chaiyaratana W, Tangnararatchakit K, Yoksan S, Flamand M, Sakuntabhai A. 2011. Dengue nonstructural protein 1 antigen in the urine as a rapid and convenient diagnostic test during the febrile stage in patients with dengue infection. Diagn Microbiol Infect Dis 71:467–469.
13. Cochran WG. 1950. The comparison of percentages in matched samples. Biometrika 37:256–266.
14. de Morais Bronzoni R, Baleotti F, Ribeiro Nogueira R, Nunes M, Moraes Figueiredo L. 2005. Duplex reverse transcription-PCR followed by nested PCR assays for detection and identification of Brazilian alphaviruses and flaviviruses. J Clin Microbiol 43:696–702.
15. Dos Santos HW, Poloni TR, Souza KP, Muller VD, Tremeschin F, Nali LC, Fantinatti LR, Amarilla AA, Castro HL, Nunes MR, Casseb SM, Vasconcelos PF, Badra SJ, Figueiredo LT, Aquino VH. 2008. A simple one-step real-time RT-PCR for diagnosis of dengue virus infection. J Med Virol 80:1426–1433.
16. Drumond B, Mondini A, Schmidt D, de Morais Bronzoni R, Bosch I, Nogueira M. 2013. Circulation of different lineages of Dengue virus 2, genotype American/Asian in Brazil: Dynamics and molecular and phylogenetic characterization. PLoS ONE 8:e59422.
17. Drumond BP, Mondini A, Schmidt DJ, Bosch I, Nogueira ML. 2012. Population dynamics of DENV-1 genotype V in Brazil is characterized by co-circulation and strain/lineage replacement. Arch Virol 157:2061–2073.
18. Editorial. 2007. Dengue fever climbs the social ladder. Nature 16:734–735.
19. Figueiredo LT, Owa MA, Carlucci RH, dal Fabbro AL, de Mello NV, Capuano DM, Santili MB. 1995. Dengue serologic survey in Ribeirão Preto, São Paulo, Brazil. Bull Pan Am Health Organ 29:59–69.
20. Fischer DB, Halstead SB. 1970. Observations related to pathogenesis of dengue hemorrhagic fever. V. Examination of agspecific sequential infection rates using a mathematical model. Yale J Biol Med 42:329–349.
21. Gordon A, Kuan G, Mercado JC, Gresh L, Avilés W, Balmaseda A, Harris E. 2013. The Nicaraguan pediatric dengue cohort study: Incidence of inapparent and symptomatic dengue virus infections, 2004–2010. PLoS Negl Trop Dis 7:e2462.
22. Halstead S. 1980. Immunological parameters of Togavirus disease syndromes. In: Schlesinger R, editor. The togaviruses, biology, structure, replication. New York: Academic Press, pp 107–137.
23. Halstead S. 2007a. Dengue. Lancet 370:1644–1652.
24. Halstead SB. 2007b. Dengue. Lancet 370:1644–1652.
25. Halstead SB, Scanlon JE, Umpaivit P, Udomsakdi S. 1969. Dengue and chikungunya virus infection in man in Thailand, 1962–1964. IV. Epidemiologic studies in the Bangkok metropolitan area. Am J Trop Med Hyg 18:997–1021.
26. Heritage J, Chesters PM, McCance DJ. 1981. The persistence of papovavirus BK DNA sequences in normal human renal tissue. J Med Virol 8:143–150.
27. Hino P, dos Santos CC, dos Santos MO, da Cunha TN, dos Santos CB. 2010. Temporal evolution of dengue fever in Ribeirão Preto, São Paulo State, 1994–2003. Cien Saude Colet 15:233–238.
28. Hirayama T, Mizuno Y, Takeshita N, Kotaki A, Tajima S, Omatsu T, Sano K, Kurane I, Takasaki T. 2012. Detection of dengue virus genome in urine by real-time reverse transcriptase PCR: A laboratory diagnostic method useful after disappearance of the genome in serum. J Clin Microbiol 50:2047–2052.
29. Instituto Brasileiro de Geografia e Estatistica I. 2010. Censo 2010.
30. Karande S, Gandhi D, Kulkarni M, Bharadwaj R, Pol S, Thakare J, De A. 2005. Concurrent outbreak of leptospirosis and dengue in Mumbai, India, 2002. J Trop Pediatr 51:174–181.
31. Korhonen EM, Huhtamo E, Virtala AM, Kantele A, Vapalahti O. 2014. Approach to non-invasive sampling in dengue diagnostics: Exploring virus and NS1 antigen detection in saliva and urine of travelers with dengue. J Clin Virol 61:353–358.
32. Larkin M, Blackshields G, Brown N, Chenna R, McGettigan P, McWilliam H, Valentin F, Wallace I, Wilm A, Lopez R, Thompson J, Gibson T, Higgins D. 2007. Clustal W and Clustal X version 2.0. Bioinformatics 23:2947–2948.
33. Martínez Torres E. 2006. Preventing deaths from dengue: A space and challenge for primary health care. Rev Panam Salud Publica 20:60–74.
34. Miranda SJC. 2011. Boletim epidemiológico mensal—Dengue. In: Saúde DdVe, editor. Ribeirão Preto: Secretaria Municipal da Saúde de Ribeirão Preto.
35. Mizuno Y, Kotaki A, Harada F, Tajima S, Kurane I, Takasaki T. 2007. Confirmation of dengue virus infection by detection of dengue virus type 1 genome in urine and saliva but not in plasma. Trans R Soc Trop Med Hyg 101:738–739.
36. 2 from Crotalus durissus terrificus showed antiviral activity against dengue and yellow fever viruses. Toxicon 59:507–515.
37. Muller VD, Soares RO, Dos Santos-Junior NN, Trabuco AC, Cintra AC, Figueiredo LT, Caliri A, Sampaio SV, Aquino VH. 2014. Phospholipase A2 isolated from the venom of Crotalus durissus terrificus inactivates dengue virus and other enveloped viruses by disrupting the viral envelope. PLoS ONE 9:e112351.
38. Nichols WG, Boeckh M. 2000. Recent advances in the therapy and prevention of CMV infections. J Clin Virol 16:25–40.
39. Nogueira R, Miagostovich M, de Filippis A, Pereira M, Schatzmayr H. 2001. Dengue virus type 3 in Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz 96:925–926.
40. Pires Neto RaJ, de Sá SL, Pinho SC, Pucci FH, Teófilo CR, Evangelista PD, Thé CS, Bezerra DE, Lima JC, Ponte HJ, Daher EeF, Coelho IC. 2013. Dengue infection in children and adolescents: Clinical profile in a reference hospital in northeast Brazil. Rev Soc Bras Med Trop 46:765–768.
41. Poloni TR, Oliveira AS, Alfonso HL, Galvao LR, Amarilla AA, Poloni DF, Figueiredo LT, Aquino VH. 2010. Detection of dengue virus in saliva and urine by real time RT-PCR. Virol J 7:1–4.
42. Rocha LA, Braga Júnior LL, Rey LC, Del Fabro MFDF, Gomin MLCG, Marques SM. 2011. Dengue: Diagnóstico e manejo clínico—crianças. In: Epidemiológica V, editor. 1 ed. Brasilia: Ministério da Saúde do Brasil. 52.
43. Rodrigues EM, Dal-Fabbro AL, Salomao R, Ferreira IB, Rocco IM, Fonseca BA. 2002. Epidemiology of dengue infection in Ribeirão Preto, SP, Brazil. Rev Saude Publica 36:160–165.
44. Rothan HA, Buckle MJ, Ammar YA, Mohammadjavad P, Shatrah O, Noorsaadah AR, Rohana Y. 2013. Study the antiviral activity of some derivatives of tetracycline and non-steroid anti inflammatory drugs towards dengue virus. Trop Biomed 30:681–690.
45. Russo RR, Müller VDM, Cintra ACO, Figueiredo LTM, Sampaio SV, Aquino VH. 2014. Phospholipase A2 crotoxin B isolated from the venom of Crotalus durissus terrificus exert antiviral effect against dengue virus and yellow fever virus through its catalytic activity. J Virol Antiviral Res 3:1–3.
46. San Martín JL, Brathwaite O, Zambrano B, Solórzano JO, Bouckenooghe A, Dayan GH, Guzmán MG. 2010. The epidemiology of dengue in the americas over the last three decades: A worrisome reality. Am J Trop Med Hyg 82:128–135.
47. Sawasdivorn S, Vibulvattanakit S, Sasavatpakdee M, Iamsirithavorn S. 2001. Efficacy of clinical diagnosis of dengue fever in paediatric age groups as determined by WHO case definition 1997 in Thailand. Dengue Bull 25:56–64.
48. Shu P, Chen L, Chang S, Yueh Y, Chow L, Chien L, Chin C, Lin T, Huang J. 2003. Comparison of capture immunoglobulin M (IgM) and IgG enzyme-linked immunosorbent assay (ELISA) and nonstructural protein NS1 serotype-specific IgG ELISA for differentiation of primary and secondary dengue virus infections. Clin Diagn Lab Immunol 10:622–630.
49. Siqueira JB, Martelli CM, Coelho GE, Simplicio AC, Hatch DL. 2005. Dengue and dengue hemorrhagic fever, Brazil, 1981–2002. Emerg Infect Dis 11:48–53.
50. Standish K, Kuan G, Avilés W, Balmaseda A, Harris E. 2010. High dengue case capture rate in four years of a cohort study in Nicaragua compared to national surveillance data. PLoS Negl Trop Dis 4:e633.
51. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. 2011. MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28:2731–2739.
52. Teixeira MG, Costa MaC Barreto F, Barreto ML. 2009. Dengue: Twenty-five years since reemergence in Brazil. Cad Saude Publica 25:S7–18.
53. Teixeira MG, Costa MC, Coelho G, Barreto ML. 2008. Recent shift in age pattern of dengue hemorrhagic fever, Brazil. Emerg Infect Dis 14:1663.
54. Teixeira MG, Siqueira JB, Ferreira GL, Bricks L, Joint G. 2013. Epidemiological trends of dengue disease in Brazil (2000–2010): A systematic literature search and analysis. PLoS Negl Trop Dis 7:e2520.
55. Temporao JG, Penna GO, Carmo EH, Coelho GE, do Socorro Silva Azevedo R, Teixeira Nunes MR, da Costa Vasconcelos PF. Dengue virus serotype 4, Roraima State, Brazil. Emerg Infect Dis 17:938–940.
56. Toledo KA, Fermino ML, Andrade CeC, Riul TB, Alves RT, Muller VD, Russo RR, Stowell SR, Cummings RD, Aquino VH, Dias-Baruffi M. 2014. Galectin-1 exerts inhibitory effects during DENV-1 infection. PLoS ONE 9:e112474.
57. Vera DdS, Miranda SCP, Santa Maria ML, Pegoraro IB. 2014. Plano Municipal de Ações para o Controle da Dengue. In: Saúde SMd, editor. Ribeirão Preto: Prefeitura Municipal de Ribeirão Preto.
58. Vázquez S, Cabezas S, Pérez A, Pupo M, Ruiz D, Calzada N, Bernardo L, Castro O, González D, Serrano T, Sanchez A, Guzmán M. 2007. Kinetics of antibodies in sera, saliva, and urine samples from adult patients with primary or secondary dengue 3 virus infections. Int J Infect Dis 11:256–262.
59. Wagner RP, Tian H, McPherson MJ, Latham PS, Orenstein JM. 1996. AIDS-associated infections in salivary glands: Autopsy survey of 60 cases. Clin Infect Dis 22:369–371.
60. WHO. 1997. Dengue haemorrhagic fever: Diagnosis, treatment, prevention and control. 2nd ed. Geneva: World Health Organization.
61. WHO. 2009. Dengue: Guidelines for diagnosis, treatment, prevention and control. Geneva: World Health Organization.
62. Wichmann O, Yoon IK, Vong S, Limkittikul K, Gibbons RV, Mammen MP, Ly S, Buchy P, Sirivichayakul C, Buathong R, Huy R, Letson GW, Sabchareon A. 2011. Dengue in Thailand and Cambodia: An assessment of the degree of underrecognized disease burden based on reported cases. PLoS Negl Trop Dis 5:e996.